VANCOUVER, BC , Feb. 18, 2025 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, today announced a change in its Chief Financial Officer position. Effective February 18, 2025, Kelvin Yang will assume the role of Interim Chief Financial Officer, replacing Melony Valleau, who will be concluding her interim tenure at the end of February.
The Company thanks Ms. Valleau for her contributions and leadership during her tenure as Interim CFO.
Mr. Yang brings regulatory and compliance experience and will oversee the Company’s financial operations as it navigates its current strategic initiatives.
This transition has been approved by the Board of Directors and aligns with the Company’s ongoing corporate planning.
About Numinus
Numinus Wellness Inc. (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – technology-driven clinic support, clinical trial research and comprehensive practitioner training – is at the forefront of a transformation aimed at healing rather than managing symptoms of depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, and Instagram.
